A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy
Clinical trial NCT05924438 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05924438
- Sponsor
- Professor Francois Venter
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2026-06-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.